Quimiossensibilizantes sintéticos e naturais associados a antifúngicos convencionais frente a Fusarium spp.
Autor(a) principal: | |
---|---|
Data de Publicação: | 2016 |
Tipo de documento: | Tese |
Idioma: | por |
Título da fonte: | Manancial - Repositório Digital da UFSM |
Texto Completo: | http://repositorio.ufsm.br/handle/1/18081 |
Resumo: | The genus Fusarium is characterized by hyaline filamentous fungi that cause a wide spectrum of infections predominantly in immunocompromised patients. Disseminated fusariosis results in high rates of morbidity and mortality, since it is of difficult prevention and treatment. The remarkable primary resistance to conventional antifungals of this genus requires the search for new therapeutic possibilities. A possible attempt is the combination of antifungals and chemosensitizing agents with different mechanisms of action. This study aimed to evaluate the in vitro susceptibility of Fusarium to conventional antifungal agents (amphotericin B, itraconazole, voriconazole and caspofungin); organoselenium compounds (diphenyl diselenide and ebselen), nonantifungal drugs (amiodarone, doxycycline, moxifloxacin, pentamidine, polymyxin B, tigecycline and tobramycin), and phytocompounds (cinnamaldehyde, carvacrol and thymol), through broth microdilution method (M38-A2, CLSI). The combinations between the antifungal agents and chemosensitizers were assessed through the checkerboard technique. Among the antifungals tested amphotericin B showed greater activity in vitro (0.25-8 μg/ml); followed by voriconazole (1-16 μg/ml), itraconazole (>16 μg/ml) and caspofungin (>32 μg/ml). Diphenyl diselenide (4-32 μg/ml), ebselen (2-8 μg/ml), pentamidine (4-32 μg/ml) and polymyxin B (4-16 μg/ml) also showed antifungal activity against Fusarium spp. Ebselen and diphenyl diselenide presented high rates of synergism in combination with amphotericin B (88% and 72%, respectively) or voriconazole (80% e 64%, respectively). Combinations with nonantifungal drugs have also resulted in synergism, highlighting the following associations (% of synergism): tobramycin + amphotericin B (80%) or voriconazole (76%); polymyxin B + amphotericin B (76%) or voriconazole (64%); pentamidine + amphotericin B (72%) or voriconazole (68%); amiodarone + amphotericin B (64%) or voriconazole (76%); and moxifloxacin + amphotericin B (72%) or voriconazole (60%). Furthermore, the phytocompounds thymol and carvacrol have showed potent chemosensitizer activity in association to caspofungin (96% e 88%, respectively). Among all the tested combinations, no antagonistic interactions were observed. In conclusion, the most relevant combinations deserve a future investigation in vivo experimental models, since these associations suggest new potencial candidates for combined therapy against fusariosis. |
id |
UFSM-20_c174cc2b2621978dfb24408b82be2bcb |
---|---|
oai_identifier_str |
oai:repositorio.ufsm.br:1/18081 |
network_acronym_str |
UFSM-20 |
network_name_str |
Manancial - Repositório Digital da UFSM |
repository_id_str |
3913 |
spelling |
2019-08-29T20:38:52Z2019-08-29T20:38:52Z2016-03-24http://repositorio.ufsm.br/handle/1/18081The genus Fusarium is characterized by hyaline filamentous fungi that cause a wide spectrum of infections predominantly in immunocompromised patients. Disseminated fusariosis results in high rates of morbidity and mortality, since it is of difficult prevention and treatment. The remarkable primary resistance to conventional antifungals of this genus requires the search for new therapeutic possibilities. A possible attempt is the combination of antifungals and chemosensitizing agents with different mechanisms of action. This study aimed to evaluate the in vitro susceptibility of Fusarium to conventional antifungal agents (amphotericin B, itraconazole, voriconazole and caspofungin); organoselenium compounds (diphenyl diselenide and ebselen), nonantifungal drugs (amiodarone, doxycycline, moxifloxacin, pentamidine, polymyxin B, tigecycline and tobramycin), and phytocompounds (cinnamaldehyde, carvacrol and thymol), through broth microdilution method (M38-A2, CLSI). The combinations between the antifungal agents and chemosensitizers were assessed through the checkerboard technique. Among the antifungals tested amphotericin B showed greater activity in vitro (0.25-8 μg/ml); followed by voriconazole (1-16 μg/ml), itraconazole (>16 μg/ml) and caspofungin (>32 μg/ml). Diphenyl diselenide (4-32 μg/ml), ebselen (2-8 μg/ml), pentamidine (4-32 μg/ml) and polymyxin B (4-16 μg/ml) also showed antifungal activity against Fusarium spp. Ebselen and diphenyl diselenide presented high rates of synergism in combination with amphotericin B (88% and 72%, respectively) or voriconazole (80% e 64%, respectively). Combinations with nonantifungal drugs have also resulted in synergism, highlighting the following associations (% of synergism): tobramycin + amphotericin B (80%) or voriconazole (76%); polymyxin B + amphotericin B (76%) or voriconazole (64%); pentamidine + amphotericin B (72%) or voriconazole (68%); amiodarone + amphotericin B (64%) or voriconazole (76%); and moxifloxacin + amphotericin B (72%) or voriconazole (60%). Furthermore, the phytocompounds thymol and carvacrol have showed potent chemosensitizer activity in association to caspofungin (96% e 88%, respectively). Among all the tested combinations, no antagonistic interactions were observed. In conclusion, the most relevant combinations deserve a future investigation in vivo experimental models, since these associations suggest new potencial candidates for combined therapy against fusariosis.O gênero Fusarium é caracterizado por fungos filamentosos hialinos que causam um amplo espectro de infecções predominantemente em pacientes imunocomprometidos. A fusariose disseminada resulta em elevados índices de morbidade e mortalidade, sendo uma infecção de difícil prevenção e tratamento. A marcante resistência primária deste gênero aos antifúngicos convencionais impõe a busca por novas possibilidades terapêuticas. Uma alternativa é a combinação entre agentes antifúngicos e quimiossensibilizantes com diferentes mecanismos de ação. Este estudo objetivou avaliar a suscetibilidade in vitro de espécies de Fusarium a antifúngicos convencionais (anfotericina B, itraconazol, voriconazol e caspofungina), compostos orgânicos de selênio (disseleneto de difenila e ebselen), fármacos não antifúngicos (amiodarona, doxiciclina, moxifloxacina, pentamidina, polimixina B, tigeciclina e tobramicina) e fitocompostos (cinamaldeído, carvacrol e timol), através do método de microdiluição em caldo (M38-A2, CLSI). As combinações entre os agentes antifúngicos e quimiossensibilizantes foram avaliadas através da técnica de checkerboard. Entre os antifúngicos testados, a anfotericina B demonstrou maior atividade in vitro (0,25-8 μg/ml); seguida pelo voriconazol (1-16 μg/ml), itraconazol (>16 μg/ml) e caspofungina (>32 μg/ml). O disseleneto de difenila (4-32 μg/ml), ebselen (2-8 μg/ml), pentamidina (4-32 μg/ml) e polimixina B (4-16 μg/ml) também demonstraram atividade antifúngica contra Fusarium spp. Ebselen e disseleneto de difenila apresentaram altas taxas de sinergismos em combinação com anfotericina B (88% e 72%, respectivamente) ou voriconazol (80% e 64%, respectivamente). As combinações com fármacos não antifúngicos também resultaram em sinergismos, destacando-se as seguintes associações (% de sinergismo): tobramicina + anfotericina B (80%) ou voriconazol (76%); polimixina B + anfotericina B (76%) ou voriconazol (64%); pentamidina + anfotericina B (72%) ou voriconazol (68%); amiodarona + anfotericina B (64%) ou voriconazol (76%); e moxifloxacina + anfotericina B (72%) ou voriconazol (60%). Além disso, os fitocompostos, timol e carvacrol demonstraram potente atividade quimiossensibilizante em associação com caspofungina (96% e 88%, respectivamente). Entre todas as combinações testadas não foram observadas interações antagônicas. Em conclusão, as combinações mais relevantes merecem uma futura investigação em modelos experimentais in vivo, pois estas associações apontam novos candidatos potenciais para a terapia combinada da fusariose.Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul.porUniversidade Federal de Santa MariaCentro de Ciências da SaúdePrograma de Pós-Graduação em Ciências FarmacêuticasUFSMBrasilFarmacologiaAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessSuscetibilidadeQuimissensibilizantesAssociaçõesAntifúngicosSinergismoFusarium spp.SusceptibilityChemosensitizersAssociationsAntifungalsSynergismCNPQ::CIENCIAS DA SAUDE::FARMACIAQuimiossensibilizantes sintéticos e naturais associados a antifúngicos convencionais frente a Fusarium spp.Synthetic and natural chemosensitizers associated with conventional antifungals against Fusarium spp.info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesisAlves, Sydney Hartzhttp://lattes.cnpq.br/0330782478769631Fuentefria, Alexandre Meneghellohttp://lattes.cnpq.br/3011308324416888Lopes, Paulo Guilherme Markushttp://lattes.cnpq.br/0280182736721337Trindade, Priscila de Arrudahttp://lattes.cnpq.br/0124362929241308http://lattes.cnpq.br/4390852722353821Venturini, Tarcieli Pozzebon400300000005600bfe6016c-9c1e-42ca-ab1d-db5453ed090cc0b26698-69fc-4115-a19f-73c221213313edc762e8-b952-4bb7-8fe6-424a950bac8c6a3b4699-c76a-4ced-9819-9d81d5aa4fc143546305-915c-443c-8ae5-09b88645907ereponame:Manancial - Repositório Digital da UFSMinstname:Universidade Federal de Santa Maria (UFSM)instacron:UFSMCC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8805http://repositorio.ufsm.br/bitstream/1/18081/2/license_rdf4460e5956bc1d1639be9ae6146a50347MD52LICENSElicense.txtlicense.txttext/plain; charset=utf-81956http://repositorio.ufsm.br/bitstream/1/18081/3/license.txt2f0571ecee68693bd5cd3f17c1e075dfMD53ORIGINALTES_PPGCF_2016_VENTURINI_TARCIELI.pdfTES_PPGCF_2016_VENTURINI_TARCIELI.pdfTese de Doutoradoapplication/pdf2332490http://repositorio.ufsm.br/bitstream/1/18081/1/TES_PPGCF_2016_VENTURINI_TARCIELI.pdf4d1986b8c5def5caa6d06356429e321aMD51TEXTTES_PPGCF_2016_VENTURINI_TARCIELI.pdf.txtTES_PPGCF_2016_VENTURINI_TARCIELI.pdf.txtExtracted texttext/plain301433http://repositorio.ufsm.br/bitstream/1/18081/4/TES_PPGCF_2016_VENTURINI_TARCIELI.pdf.txtdbb6cadfd1b9bab8a304b760d4d6d526MD54THUMBNAILTES_PPGCF_2016_VENTURINI_TARCIELI.pdf.jpgTES_PPGCF_2016_VENTURINI_TARCIELI.pdf.jpgIM Thumbnailimage/jpeg4265http://repositorio.ufsm.br/bitstream/1/18081/5/TES_PPGCF_2016_VENTURINI_TARCIELI.pdf.jpge25616c2fe9b47012e58263a1a28a216MD551/180812019-08-30 03:02:16.964oai:repositorio.ufsm.br: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ório Institucionalhttp://repositorio.ufsm.br/PUBhttp://repositorio.ufsm.br/oai/requestopendoar:39132019-08-30T06:02:16Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)false |
dc.title.por.fl_str_mv |
Quimiossensibilizantes sintéticos e naturais associados a antifúngicos convencionais frente a Fusarium spp. |
dc.title.alternative.eng.fl_str_mv |
Synthetic and natural chemosensitizers associated with conventional antifungals against Fusarium spp. |
title |
Quimiossensibilizantes sintéticos e naturais associados a antifúngicos convencionais frente a Fusarium spp. |
spellingShingle |
Quimiossensibilizantes sintéticos e naturais associados a antifúngicos convencionais frente a Fusarium spp. Venturini, Tarcieli Pozzebon Suscetibilidade Quimissensibilizantes Associações Antifúngicos Sinergismo Fusarium spp. Susceptibility Chemosensitizers Associations Antifungals Synergism CNPQ::CIENCIAS DA SAUDE::FARMACIA |
title_short |
Quimiossensibilizantes sintéticos e naturais associados a antifúngicos convencionais frente a Fusarium spp. |
title_full |
Quimiossensibilizantes sintéticos e naturais associados a antifúngicos convencionais frente a Fusarium spp. |
title_fullStr |
Quimiossensibilizantes sintéticos e naturais associados a antifúngicos convencionais frente a Fusarium spp. |
title_full_unstemmed |
Quimiossensibilizantes sintéticos e naturais associados a antifúngicos convencionais frente a Fusarium spp. |
title_sort |
Quimiossensibilizantes sintéticos e naturais associados a antifúngicos convencionais frente a Fusarium spp. |
author |
Venturini, Tarcieli Pozzebon |
author_facet |
Venturini, Tarcieli Pozzebon |
author_role |
author |
dc.contributor.advisor1.fl_str_mv |
Alves, Sydney Hartz |
dc.contributor.advisor1Lattes.fl_str_mv |
http://lattes.cnpq.br/0330782478769631 |
dc.contributor.referee1.fl_str_mv |
Fuentefria, Alexandre Meneghello |
dc.contributor.referee1Lattes.fl_str_mv |
http://lattes.cnpq.br/3011308324416888 |
dc.contributor.referee2.fl_str_mv |
Lopes, Paulo Guilherme Markus |
dc.contributor.referee2Lattes.fl_str_mv |
http://lattes.cnpq.br/0280182736721337 |
dc.contributor.referee3.fl_str_mv |
Trindade, Priscila de Arruda |
dc.contributor.referee3Lattes.fl_str_mv |
http://lattes.cnpq.br/0124362929241308 |
dc.contributor.authorLattes.fl_str_mv |
http://lattes.cnpq.br/4390852722353821 |
dc.contributor.author.fl_str_mv |
Venturini, Tarcieli Pozzebon |
contributor_str_mv |
Alves, Sydney Hartz Fuentefria, Alexandre Meneghello Lopes, Paulo Guilherme Markus Trindade, Priscila de Arruda |
dc.subject.por.fl_str_mv |
Suscetibilidade Quimissensibilizantes Associações Antifúngicos Sinergismo Fusarium spp. |
topic |
Suscetibilidade Quimissensibilizantes Associações Antifúngicos Sinergismo Fusarium spp. Susceptibility Chemosensitizers Associations Antifungals Synergism CNPQ::CIENCIAS DA SAUDE::FARMACIA |
dc.subject.eng.fl_str_mv |
Susceptibility Chemosensitizers Associations Antifungals Synergism |
dc.subject.cnpq.fl_str_mv |
CNPQ::CIENCIAS DA SAUDE::FARMACIA |
description |
The genus Fusarium is characterized by hyaline filamentous fungi that cause a wide spectrum of infections predominantly in immunocompromised patients. Disseminated fusariosis results in high rates of morbidity and mortality, since it is of difficult prevention and treatment. The remarkable primary resistance to conventional antifungals of this genus requires the search for new therapeutic possibilities. A possible attempt is the combination of antifungals and chemosensitizing agents with different mechanisms of action. This study aimed to evaluate the in vitro susceptibility of Fusarium to conventional antifungal agents (amphotericin B, itraconazole, voriconazole and caspofungin); organoselenium compounds (diphenyl diselenide and ebselen), nonantifungal drugs (amiodarone, doxycycline, moxifloxacin, pentamidine, polymyxin B, tigecycline and tobramycin), and phytocompounds (cinnamaldehyde, carvacrol and thymol), through broth microdilution method (M38-A2, CLSI). The combinations between the antifungal agents and chemosensitizers were assessed through the checkerboard technique. Among the antifungals tested amphotericin B showed greater activity in vitro (0.25-8 μg/ml); followed by voriconazole (1-16 μg/ml), itraconazole (>16 μg/ml) and caspofungin (>32 μg/ml). Diphenyl diselenide (4-32 μg/ml), ebselen (2-8 μg/ml), pentamidine (4-32 μg/ml) and polymyxin B (4-16 μg/ml) also showed antifungal activity against Fusarium spp. Ebselen and diphenyl diselenide presented high rates of synergism in combination with amphotericin B (88% and 72%, respectively) or voriconazole (80% e 64%, respectively). Combinations with nonantifungal drugs have also resulted in synergism, highlighting the following associations (% of synergism): tobramycin + amphotericin B (80%) or voriconazole (76%); polymyxin B + amphotericin B (76%) or voriconazole (64%); pentamidine + amphotericin B (72%) or voriconazole (68%); amiodarone + amphotericin B (64%) or voriconazole (76%); and moxifloxacin + amphotericin B (72%) or voriconazole (60%). Furthermore, the phytocompounds thymol and carvacrol have showed potent chemosensitizer activity in association to caspofungin (96% e 88%, respectively). Among all the tested combinations, no antagonistic interactions were observed. In conclusion, the most relevant combinations deserve a future investigation in vivo experimental models, since these associations suggest new potencial candidates for combined therapy against fusariosis. |
publishDate |
2016 |
dc.date.issued.fl_str_mv |
2016-03-24 |
dc.date.accessioned.fl_str_mv |
2019-08-29T20:38:52Z |
dc.date.available.fl_str_mv |
2019-08-29T20:38:52Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/doctoralThesis |
format |
doctoralThesis |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://repositorio.ufsm.br/handle/1/18081 |
url |
http://repositorio.ufsm.br/handle/1/18081 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.cnpq.fl_str_mv |
400300000005 |
dc.relation.confidence.fl_str_mv |
600 |
dc.relation.authority.fl_str_mv |
bfe6016c-9c1e-42ca-ab1d-db5453ed090c c0b26698-69fc-4115-a19f-73c221213313 edc762e8-b952-4bb7-8fe6-424a950bac8c 6a3b4699-c76a-4ced-9819-9d81d5aa4fc1 43546305-915c-443c-8ae5-09b88645907e |
dc.rights.driver.fl_str_mv |
Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Universidade Federal de Santa Maria Centro de Ciências da Saúde |
dc.publisher.program.fl_str_mv |
Programa de Pós-Graduação em Ciências Farmacêuticas |
dc.publisher.initials.fl_str_mv |
UFSM |
dc.publisher.country.fl_str_mv |
Brasil |
dc.publisher.department.fl_str_mv |
Farmacologia |
publisher.none.fl_str_mv |
Universidade Federal de Santa Maria Centro de Ciências da Saúde |
dc.source.none.fl_str_mv |
reponame:Manancial - Repositório Digital da UFSM instname:Universidade Federal de Santa Maria (UFSM) instacron:UFSM |
instname_str |
Universidade Federal de Santa Maria (UFSM) |
instacron_str |
UFSM |
institution |
UFSM |
reponame_str |
Manancial - Repositório Digital da UFSM |
collection |
Manancial - Repositório Digital da UFSM |
bitstream.url.fl_str_mv |
http://repositorio.ufsm.br/bitstream/1/18081/2/license_rdf http://repositorio.ufsm.br/bitstream/1/18081/3/license.txt http://repositorio.ufsm.br/bitstream/1/18081/1/TES_PPGCF_2016_VENTURINI_TARCIELI.pdf http://repositorio.ufsm.br/bitstream/1/18081/4/TES_PPGCF_2016_VENTURINI_TARCIELI.pdf.txt http://repositorio.ufsm.br/bitstream/1/18081/5/TES_PPGCF_2016_VENTURINI_TARCIELI.pdf.jpg |
bitstream.checksum.fl_str_mv |
4460e5956bc1d1639be9ae6146a50347 2f0571ecee68693bd5cd3f17c1e075df 4d1986b8c5def5caa6d06356429e321a dbb6cadfd1b9bab8a304b760d4d6d526 e25616c2fe9b47012e58263a1a28a216 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 MD5 |
repository.name.fl_str_mv |
Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM) |
repository.mail.fl_str_mv |
|
_version_ |
1801223679597608960 |